title: From the guest editor: The rise of CAR therapy: the CD19 paradigm, and beyond. Introduction.
authors.affiliation: From the Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Michel
authors.initials: M
authors.lastname: Sadelain
mesh_terms: D000939:Epitopes / Q000276:immunology; D006801:Humans; D016219:Immunotherapy, Adoptive; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D015514:Oncogene Proteins, Fusion / Q000235:genetics / Q000276:immunology* / Q000627:therapeutic use; D011948:Receptors, Antigen, T-Cell / Q000235:genetics / Q000276:immunology* / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology
chemical_list: D000939:Epitopes; D015514:Oncogene Proteins, Fusion; D011948:Receptors, Antigen, T-Cell